TRCT
HURA

Tower Research Capital (TRC)’s TuHURA Biosciences HURA Stock Holding History

Tower Research Capital (TRC)’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.7K Buy
18,679
+9,802
+110% +$22.8K ﹤0.01% 2846
2026
Q1 		$15.9K Buy
8,877
+812
+10% +$995 ﹤0.01% 3648
2025
Q4 		$6.1K Buy
8,065
+3,700
+85% +$7.08K ﹤0.01% 4076
2025
Q3 		$10.8K Buy
+4,365
New +$11.5K ﹤0.01% 3949
2024
Q4 		– Sell
-282
Closed -$1.92K – 6085
2024
Q3 		$1.92K Buy
282
+232
+464% +$1.73K ﹤0.01% 5082
2024
Q2 		$468 Sell
50
-473
-90% -$2.94K ﹤0.01% 5320
2024
Q1 		$1.9K Buy
523
+384
+276% +$1.54K ﹤0.01% 5160
2023
Q4 		$825 Buy
139
+94
+209% +$4.86K ﹤0.01% 5490
2023
Q3 		$6.33K Sell
45
-91
-67% -$13.4K ﹤0.01% 4615
2023
Q2 		$19.3K Buy
136
+85
+167% +$9.67K ﹤0.01% 3417
2023
Q1 		$6K Buy
51
+35
+219% +$6.75K ﹤0.01% 4900
2022
Q4 		$4K Sell
16
-1
-6% -$222 ﹤0.01% 5089
2022
Q3 		$3K Sell
17
-2
-11% -$639 ﹤0.01% 5446
2022
Q2 		$9K Buy
19
+11
+138% +$4.79K ﹤0.01% 4598
2022
Q1 		$6K Buy
+8
New +$5.76K ﹤0.01% 4946
2021
Q3 		– Sell
-2
Closed -$7K – 6253
2021
Q2 		$7K Buy
+2
New +$5.75K ﹤0.01% 4574
2021
Q1 		– Sell
-5
Closed -$10K – 5790
2020
Q4 		$10K Buy
5
+4
+400% +$10K ﹤0.01% 4330
2020
Q3 		$3K Buy
+1
New +$2.01K ﹤0.01% 4539
2017
Q1 		– Hold
0
– -$1K – 4038
2016
Q4 		– Hold
0
– – – 3672
2016
Q3 		– Hold
0
– – – 2590

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Tower Research Capital (TRC)'s HURA Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its TuHURA Biosciences (HURA) stake by 110% in Q2 2026, buying an estimated $22.8K and bringing the position to 18,679 shares worth $43.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2846.

Tower Research Capital (TRC) first reported a position in HURA in Q3 2020 and has held it in 18 quarters since. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Tower Research Capital (TRC) held 18,679 shares of TuHURA Biosciences worth $43.7K as of Q2 2026.
  • Tower Research Capital (TRC) bought 9,802 TuHURA Biosciences shares in Q2 2026, an estimated $22.8K.
  • TuHURA Biosciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2846 holding.
  • Tower Research Capital (TRC) first reported a position in TuHURA Biosciences in Q3 2020 and has held it in 18 quarters since.
  • 90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.